About: Interplay between cost and effectiveness in influenza vaccine uptake: a vaccination game approach

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Interplay between cost and effectiveness in influenza vaccine uptake: a vaccination game approach Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Interplay between cost and effectiveness in influenza vaccine uptake: a vaccination game approach
Creator	Tanimoto, Jun Masaki, Tanaka Ariful Kabir, K Arefin, Md
Source	PMC
abstract	Pre-emptive vaccination is regarded as one of the most protective measures to control influenza outbreak. There are mainly two types of influenza viruses—influenza A and B with several subtypes—that are commonly found to circulate among humans. The traditional trivalent (TIV) flu vaccine targets two strains of influenza A and one strain of influenza B. The quadrivalent (QIV) vaccine targets one extra B virus strain that ensures better protection against influenza; however, the use of QIV vaccine can be costly, hence impose an extra financial burden to society. This scenario might create a dilemma in choosing vaccine types at the individual level. This article endeavours to explain such a dilemma through the framework of a vaccination game, where individuals can opt for one of the three options: choose either of QIV or TIV vaccine or none. Our approach presumes a mean-field framework of a vaccination game in an infinite and well-mixed population, entangling the disease spreading process of influenza with the coevolution of two types of vaccination decision-making processes taking place before an epidemic season. We conduct a series of numerical simulations as an attempt to illustrate different scenarios. The framework has been validated by the so-called multi-agent simulation (MAS) approach.
has issue date	2019-12-18(xsd:dateTime)
bibo:doi	10.1098/rspa.2019.0608
bibo:pmid	31892839
has license	cc-by
sha1sum (hex)	39860401de24cbae315f33d3e9566552ac45e352
schema:url	https://doi.org/10.1098/rspa.2019.0608
resource representing a document's title	Interplay between cost and effectiveness in influenza vaccine uptake: a vaccination game approach
has PubMed Central identifier	PMC6936611
has PubMed identifier	31892839
schema:publication	Proc Math Phys Eng Sci
resource representing a document's body	covid:39860401de24cbae315f33d3e9566552ac45e352#body_text
is schema:about of	named entity 'influenza vaccine' named entity 'efficacies' named entity 'free rider' named entity 'TIV' named entity 'heatmap' named entity 'vaccination' named entity 'virus' named entity 'viruses' named entity 'vaccination' named entity 'vaccination' named entity 'influenza' named entity 'vaccination' named entity 'influenza A virus' named entity 'vaccination' named entity 'TIV' named entity 'free riders' named entity 'virus' named entity 'virus' named entity 'efficacies' named entity 'heatmap' named entity 'influenza' named entity 'vaccination' named entity 'TIV' named entity 'vaccination' named entity 'vaccination' named entity 'infection' named entity 'virus' named entity 'MAS' named entity 'influenza vaccines' named entity 'cross-immunity' named entity 'epidemic' named entity 'evolution' named entity 'The strategy' named entity 'vaccination' named entity 'MAS' named entity 'MAS' named entity 'coevolution' named entity 'heatmap' named entity 'free riding' named entity 'influenza' named entity 'influenza A and B viruses' named entity 'vaccination' named entity 'influenza' named entity 'age structure' named entity 'vaccination' named entity 'viruses' named entity 'multi-agent simulation' named entity 'vaccine efficacy' named entity 'incidence rate' named entity 'epidemic' named entity 'vaccine effectiveness' named entity 'epidemic' named entity 'influenza B virus' named entity 'virus' named entity 'virus' named entity 'TIV' named entity 'influenza' named entity 'vaccination' named entity 'C V' named entity 'influenza' named entity 'vaccination' named entity 'vaccination' named entity 'transmission rate' named entity 'vaccine' named entity 'cross-immunity' named entity 'influenza viruses' named entity 'epidemic' named entity 'infection' named entity 'viruses' named entity 'epidemic' named entity 'vaccination' named entity 'viruses' named entity 'virus' named entity 'influenza' named entity 'vaccination' named entity 'MAS' named entity 'vaccination' named entity 'steady state'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software